Daily Analysis
Real-Time Analysis
-
BL-TB-529598:35p
TECH TRADER
Alphabet: Tuesday Will Showcase Software Chops, Says Jefferies
Get ready for a big push on software by 's (GOOGL) unit Tuesday morning, according to .'s
Read Full Post » -
BL-INCOMB-99096:46p
INCOME INVESTING
With Neiman Marcus Stabilizing in 2017, Bonds Look Good Now
Things should be looking up for Neiman Marcus in about a year, writes Steven Ruggiero of R.W. Pressprich Research, who put out a Buy recommendation Monday on the department store's bonds. He writes:
Read Full Post » -
BL-231B-122686:23p
EMERGING MARKETS
Q&A: Greece, Turkey, Refugees, Crisis & NATO
If the tide of refugees and migrants moving from the Middle East through Turkey to Europe surges, Greece is in big trouble.
Read Full Post » -
BL-231B-122716:14p
EMERGING MARKETS
Emerging Markets 2016: Brazil Wins, China & Greece Lose
Brazil and Peru remain the runaway victors among emerging market countries this year, while Greece and China A shares were at the bottom of the heap, according to MSCI.
Read Full Post »
Browse Recent Columns
-
Up and Down Wall Street
![[image]](https://web-archive.nli.org.il/National_Library/20161130034600im_/http://barrons.wsj.net/public/resources/images/ON-AO331_Forsyt_BC_20100602171833.gif)
Markets Cast Ballots for Clinton After Debate
September 27
Stocks rebound and Mexican peso jumps, suggesting market expects continuity in the White House.
-
Subscriber Content Read Preview
Ahead of the Crowd
![[image]](https://web-archive.nli.org.il/National_Library/20161130034600im_/http://barrons.wsj.net/public/resources/images/BP-AA014_HoughB_BC_20160202152748.jpg)
This Stock Can Rise 50% And Fetches 3x Earnings
September 30
Climb aboard. Canada’s largest airline is dramatically undervalued and free cash flow is set to soar.
-
Subscriber Content Read Preview
Getting Technical
![[image]](https://web-archive.nli.org.il/National_Library/20161130034600im_/http://barrons.wsj.net/public/resources/images/ON-AO333_Kahn_B_BC_20100602171901.gif)
How Stock Charts Work — And How to Use Them
September 29
There are hundreds of charting tools available, but most investors only need to know how to use just a few.
-
Subscriber Content Read Preview
The Striking Price
![[image]](https://web-archive.nli.org.il/National_Library/20161130034600im_/http://barrons.wsj.net/public/resources/images/ON-AO341_Sears__BC_20100602172307.gif)
You’ve Got to Be Bats Not to Buy CBOE Now
September 26
CBOE’s plan to buy Bats is a chance to get an innovator on the cusp of a radical transformation.
-
Read This, Spike That
![[image]](https://web-archive.nli.org.il/National_Library/20161130034600im_/http://barrons.wsj.net/public/resources/images/ON-BU067_kimelm_BC_20160823175815.jpg)
Is Deutsche Bank Really The Next Lehman?
September 30
The financial media debate whether the megabank has the wherewithal to avoid Lehman’s fate.
-
Subscriber Content Read Preview
Stock Alert
![[image]](https://web-archive.nli.org.il/National_Library/20161130034600im_/http://barrons.wsj.net/public/resources/images/ON-AO329_Englan_BC_20100602171717.jpg)
Red Lion Hotels Offers Lots of Room for Upside
September 22
The Vantage Hospitality acquisition expands Red Lion’s geographic reach and will lift earnings and cash flow.
Barron's Take
-
Subscriber Content Read Preview
September 30![[image]](https://web-archive.nli.org.il/National_Library/20161130034600im_/http://barrons.wsj.net/public/resources/images/ON-BU193_regene_A_20160829164123.jpg)
Regeneron Bulls Should Keep Eye on the Prize
Weak clinical trial results of a new combo eye therapy are hitting shares. But we spy a buying opportunity.
-
September 29
Subscriber Content Read Preview
Food Stocks Are Boring? ConAgra Begs to Differ
-
September 28
Subscriber Content Read Preview
Nike on the Run as Rivals Encroach on Its Turf
Weekday Trader
-
Subscriber Content Read Preview
September 23![[image]](https://web-archive.nli.org.il/National_Library/20161130034600im_/http://barrons.wsj.net/public/resources/images/ON-BU114_Biotec_A_20160826111207.jpg)
Biotech Is Cheaper Than Big Pharma: What to Buy
Biotech stocks in the S&P 500 fetch 12.2 times forward earnings, a 20% discount to pharmaceutical stocks.
-
September 16
Subscriber Content Read Preview
Vertex Looks to Cash In On Its Rich Drug Pipeline
-
August 31
Subscriber Content Read Preview
New Tracking Stock Offers Cheap Play on VMware
Wall Street's Best Minds
-
Subscriber Content Read Preview
September 29![[image]](https://web-archive.nli.org.il/National_Library/20161130034600im_/http://barrons.wsj.net/public/resources/images/ON-BT673_GregVa_A_20160804130008.jpg)
Tax Hikes in 2017? Nope!
Outside of the abolition of the “carried interest” break, a GOP House won’t go along with tax increases impacting even wealthy individuals.
-
September 28
Subscriber Content Read Preview
Pimco Expects Slight Gain in U.S. Economy
-
September 27
Subscriber Content Read Preview
Diversification Is the Winning Ticket in 2016
Q&A
-
Subscriber Content Read Preview
September 7![[image]](https://web-archive.nli.org.il/National_Library/20161130034600im_/http://barrons.wsj.net/public/resources/images/ON-BU324_davids_A_20160906170514.jpg)
7 Under-the-Radar Small-Cap Growth Stocks
The Hood River Small-Cap Growth fund is trouncing its benchmark this year by finding mispriced companies.
-
August 30
Subscriber Content Read Preview
Bond Yields Up to 12%? Here’s BlackRock’s Trade
-
August 23
Subscriber Content Read Preview
5 Dividend-Rich Stocks to Hold for the Long Term
Inside Scoop
-
Subscriber Content Read Preview
September 30![[image]](https://web-archive.nli.org.il/National_Library/20161130034600im_/http://barrons.wsj.net/public/resources/images/ON-BV063_CarTir_A_20160929192632.jpg)
Bain Capital Sells $1.7 Billion in Stock
The investment firm sells its entire stake in Trinseo, a maker of plastics, latex binders and synthetic rubber.
-
September 28
Subscriber Content Read Preview
Plastic Investor Opts for Cash With Insider Selling
-
September 27
Subscriber Content Read Preview
Two Cancer Biotechs See Bullish Insider Buying
Stock Alert
-
Subscriber Content Read Preview
September 8![[image]](https://web-archive.nli.org.il/National_Library/20161130034600im_/http://barrons.wsj.net/public/resources/images/ON-BU343_ravent_A_20160907182438.jpg)
Don’t Bet the Farm on Raven Industries Stock
The maker of tech-based equipment used to boost crop yields has jumped 62% since our January endorsement.
-
August 24
Subscriber Content Read Preview
Trinity Biotech: Stock Has More Than 50% Upside
-
August 4
Subscriber Content Read Preview
IGT Is Hardly a Gamble
Investors' Soapbox
-
Subscriber Content Read Preview
October 3![[image]](https://web-archive.nli.org.il/National_Library/20161130034600im_/http://barrons.wsj.net/public/resources/images/ON-BT172_homeco_A_20160711161513.jpg)
Two Home Builders in the Hottest Markets
CalAtlantic and KB Home have the most exposure to the top 10 new-construction housing markets in the U.S.
-
October 3
Subscriber Content Read Preview
Scottrade: Who Will Acquire It?
-
September 30
Subscriber Content Read Preview
The Tower Stock for Best Dividend Growth
Hot Research
-
Subscriber Content Read Preview
October 3![[image]](https://web-archive.nli.org.il/National_Library/20161130034600im_/http://barrons.wsj.net/public/resources/images/ON-BV173_WildWi_A_20161003060134.jpg)
Buffalo Wild Wings Looks Tame Next to Darden
A drop in NFL watching is hurting the wing slinger. Darden has solid free cash flows to support buybacks and dividends.
-
October 2
Subscriber Content Read Preview
Panera: Breaking Bread
-
September 29
Subscriber Content Read Preview
Amazon Stock Can Go Up Another $100
Weekday Trader Extra
-
Subscriber Content Read Preview
September 20![[image]](https://web-archive.nli.org.il/National_Library/20161130034600im_/http://barrons.wsj.net/public/resources/images/ON-BU701_Biotec_A_20160920145559.jpg)
Sarepta Soars 100% in a Week Yet Remains a Buy
FDA approval of Sarepta’s muscular dystrophy drug is creating a big opportunity for investors.
-
September 19
Subscriber Content Read Preview
Sarepta Still a Buy After Expedited FDA Approval
-
September 14
Subscriber Content Read Preview
Sarepta Rally Has Legs as FDA Critic Leaves Agency
Hulbert on Markets
-
Subscriber Content Read Preview
September 29![[image]](https://web-archive.nli.org.il/National_Library/20161130034600im_/http://barrons.wsj.net/public/resources/images/ON-BV033_Clinto_A_20160929062955.jpg)
Does the Market Care Who Wins in November?
The direction of interest rates will likely have a much bigger impact, according to an important new study.
-
August 25
Subscriber Content Read Preview
The Wall of Worry Just Came Tumbling Down
-
August 3
Subscriber Content Read Preview
4 Ways to Profit From a Coming Jump in Inflation